Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: Results from the American college of surgeons oncology group Z1071 Trial (Alliance) Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Lymph Nodes

abstract

  • AUS is recommended after chemotherapy to guide axillary surgery. An FNR of 9.8% with the combination of AUS and SLN surgery would be acceptable for the adoption of SLN surgery for women with node-positive breast cancer treated with neoadjuvant chemotherapy.

publication date

  • October 20, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4606058

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.57.8401

PubMed ID

  • 25646192

Additional Document Info

start page

  • 3386

end page

  • 93

volume

  • 33

number

  • 30